Sigal Charles Elliott 4
4 · Adaptimmune Therapeutics PLC · Filed Jul 1, 2022
Insider Transaction Report
Form 4
Sigal Charles Elliott
Director
Transactions
- Award
Option to purchase Ordinary Shares
2022-07-01+737,050→ 737,050 totalExercise: $0.28From: 2023-07-01Exp: 2032-07-02→ Ordinary Shares (737,050 underlying)
Footnotes (1)
- [F1]The exercise price was converted from GBP0.23 based on an exchange rate of $U.S. 1.216007 to GBP1.00. The actual exercise price will be the pounds sterling amount.